Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Intracranial Non-thermal Ablation Mediated by Transcranial Focused Ultrasound and Phase-Shift Nanoemulsions.

Peng C, Sun T, Vykhodtseva N, Power C, Zhang Y, Mcdannold N, Porter T.

Ultrasound Med Biol. 2019 Aug;45(8):2104-2117. doi: 10.1016/j.ultrasmedbio.2019.04.010. Epub 2019 May 15.

PMID:
31101446
2.

Simultaneous Passive Acoustic Mapping and Magnetic Resonance Thermometry for Monitoring of Cavitation-Enhanced Tumor Ablation in Rabbits Using Focused Ultrasound and Phase-Shift Nanoemulsions.

Crake C, Papademetriou IT, Zhang Y, Vykhodtseva N, McDannold NJ, Porter TM.

Ultrasound Med Biol. 2018 Dec;44(12):2609-2624. doi: 10.1016/j.ultrasmedbio.2018.07.023. Epub 2018 Sep 8.

PMID:
30201425
3.

Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.

Sun T, Zhang Y, Power C, Alexander PM, Sutton JT, Aryal M, Vykhodtseva N, Miller EL, McDannold NJ.

Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10281-E10290. doi: 10.1073/pnas.1713328114. Epub 2017 Nov 13.

4.

The Effects of Oxygen on Ultrasound-Induced Blood-Brain Barrier Disruption in Mice.

McDannold N, Zhang Y, Vykhodtseva N.

Ultrasound Med Biol. 2017 Feb;43(2):469-475. doi: 10.1016/j.ultrasmedbio.2016.09.019. Epub 2016 Oct 24.

5.

Preclinical evaluation of a low-frequency transcranial MRI-guided focused ultrasound system in a primate model.

McDannold N, Livingstone M, Top CB, Sutton J, Todd N, Vykhodtseva N.

Phys Med Biol. 2016 Nov 7;61(21):7664-7687. Epub 2016 Oct 14.

6.

Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.

Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N.

J Control Release. 2017 Mar 28;250:77-85. doi: 10.1016/j.jconrel.2016.10.011. Epub 2016 Oct 11.

7.

Acoustic neuromodulation from a basic science prospective.

Sassaroli E, Vykhodtseva N.

J Ther Ultrasound. 2016 May 20;4:17. doi: 10.1186/s40349-016-0061-z. eCollection 2016. Review.

8.

Nonthermal ablation in the rat brain using focused ultrasound and an ultrasound contrast agent: long-term effects.

McDannold N, Zhang Y, Vykhodtseva N.

J Neurosurg. 2016 Dec;125(6):1539-1548. Epub 2016 Feb 5.

9.

Safety Validation of Repeated Blood-Brain Barrier Disruption Using Focused Ultrasound.

Kobus T, Vykhodtseva N, Pilatou M, Zhang Y, McDannold N.

Ultrasound Med Biol. 2016 Feb;42(2):481-92. doi: 10.1016/j.ultrasmedbio.2015.10.009. Epub 2015 Nov 23.

10.

Targeted, noninvasive blockade of cortical neuronal activity.

McDannold N, Zhang Y, Power C, Arvanitis CD, Vykhodtseva N, Livingstone M.

Sci Rep. 2015 Nov 6;5:16253. doi: 10.1038/srep16253.

11.

Cavitation-enhanced nonthermal ablation in deep brain targets: feasibility in a large animal model.

Arvanitis CD, Vykhodtseva N, Jolesz F, Livingstone M, McDannold N.

J Neurosurg. 2016 May;124(5):1450-9. doi: 10.3171/2015.4.JNS142862. Epub 2015 Sep 18.

12.

Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.

Aryal M, Park J, Vykhodtseva N, Zhang YZ, McDannold N.

Phys Med Biol. 2015 Mar 21;60(6):2511-27. doi: 10.1088/0031-9155/60/6/2511. Epub 2015 Mar 6.

13.

Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.

Aryal M, Vykhodtseva N, Zhang YZ, McDannold N.

J Control Release. 2015 Apr 28;204:60-9. doi: 10.1016/j.jconrel.2015.02.033. Epub 2015 Feb 24.

14.

Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions.

Kopechek JA, Park EJ, Zhang YZ, Vykhodtseva NI, McDannold NJ, Porter TM.

Phys Med Biol. 2014 Jul 7;59(13):3465-81. doi: 10.1088/0031-9155/59/13/3465. Epub 2014 Jun 5.

15.

Nonthermal ablation with microbubble-enhanced focused ultrasound close to the optic tract without affecting nerve function.

McDannold N, Zhang YZ, Power C, Jolesz F, Vykhodtseva N.

J Neurosurg. 2013 Nov;119(5):1208-20. doi: 10.3171/2013.8.JNS122387. Epub 2013 Sep 6.

16.

Creating brain lesions with low-intensity focused ultrasound with microbubbles: a rat study at half a megahertz.

Huang Y, Vykhodtseva NI, Hynynen K.

Ultrasound Med Biol. 2013 Aug;39(8):1420-8. doi: 10.1016/j.ultrasmedbio.2013.03.006. Epub 2013 Jun 4.

17.

Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.

Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N.

J Control Release. 2013 Jul 10;169(1-2):103-11. doi: 10.1016/j.jconrel.2013.04.007. Epub 2013 Apr 18.

18.

Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring.

Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N.

PLoS One. 2012;7(9):e45783. doi: 10.1371/journal.pone.0045783. Epub 2012 Sep 24.

19.

Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.

Park EJ, Zhang YZ, Vykhodtseva N, McDannold N.

J Control Release. 2012 Nov 10;163(3):277-84. doi: 10.1016/j.jconrel.2012.09.007. Epub 2012 Sep 18.

20.

Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles.

Park J, Zhang Y, Vykhodtseva N, Akula JD, McDannold NJ.

PLoS One. 2012;7(8):e42754. doi: 10.1371/journal.pone.0042754. Epub 2012 Aug 13.

21.

Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.

Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2012 Oct;38(10):1716-25. doi: 10.1016/j.ultrasmedbio.2012.04.015. Epub 2012 Jul 19.

22.

The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.

Park J, Zhang Y, Vykhodtseva N, Jolesz FA, McDannold NJ.

J Control Release. 2012 Aug 20;162(1):134-42. doi: 10.1016/j.jconrel.2012.06.012. Epub 2012 Jun 15.

23.

Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques.

McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS.

Cancer Res. 2012 Jul 15;72(14):3652-63. doi: 10.1158/0008-5472.CAN-12-0128. Epub 2012 May 2.

24.

Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol.

McDannold N, Zhang Y, Vykhodtseva N.

Ultrasound Med Biol. 2011 Aug;37(8):1259-70. doi: 10.1016/j.ultrasmedbio.2011.04.019. Epub 2011 Jun 8.

25.
26.

Focused ultrasound effects on nerve action potential in vitro.

Colucci V, Strichartz G, Jolesz F, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2009 Oct;35(10):1737-47. doi: 10.1016/j.ultrasmedbio.2009.05.002. Epub 2009 Aug 3.

27.

Focused ultrasound treatment of VX2 tumors controlled by local harmonic motion.

Curiel L, Huang Y, Vykhodtseva N, Hynynen K.

Phys Med Biol. 2009 Jun 7;54(11):3405-19. doi: 10.1088/0031-9155/54/11/009. Epub 2009 May 13.

PMID:
19436103
28.

Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.

Vykhodtseva N, McDannold N, Hynynen K.

Ultrasonics. 2008 Aug;48(4):279-96. doi: 10.1016/j.ultras.2008.04.004. Epub 2008 Apr 14. Review.

29.

Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption.

McDannold N, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2008 Jun;34(6):930-7. doi: 10.1016/j.ultrasmedbio.2007.11.009. Epub 2008 Feb 21.

30.

Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index.

McDannold N, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2008 May;34(5):834-40. doi: 10.1016/j.ultrasmedbio.2007.10.016. Epub 2008 Jan 22.

31.

Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound.

Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K.

Int J Cancer. 2007 Aug 15;121(4):901-7.

32.

Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study.

McDannold N, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2007 Apr;33(4):584-90.

33.

Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison.

Vykhodtseva N, McDannold N, Hynynen K.

Ultrasound Med Biol. 2006 Dec;32(12):1923-9.

PMID:
17169704
34.
35.

Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz FA, Sheikov N.

J Neurosurg. 2006 Sep;105(3):445-54.

PMID:
16961141
36.

Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity.

McDannold N, Vykhodtseva N, Hynynen K.

Phys Med Biol. 2006 Feb 21;51(4):793-807. Epub 2006 Jan 25.

PMID:
16467579
37.

MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.

McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K.

Ultrasound Med Biol. 2005 Nov;31(11):1527-37.

PMID:
16286030
38.

Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N.

Neuroimage. 2005 Jan 1;24(1):12-20.

PMID:
15588592
39.

Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles.

Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K.

Ultrasound Med Biol. 2004 Jul;30(7):979-89.

PMID:
15313330
40.

500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls.

Hynynen K, Clement GT, McDannold N, Vykhodtseva N, King R, White PJ, Vitek S, Jolesz FA.

Magn Reson Med. 2004 Jul;52(1):100-7.

41.
42.

Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney.

McDannold N, Fossheim SL, Rasmussen H, Martin H, Vykhodtseva N, Hynynen K.

Radiology. 2004 Mar;230(3):743-52. Epub 2004 Feb 5.

PMID:
14764890
43.

Non-invasive opening of BBB by focused ultrasound.

Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA.

Acta Neurochir Suppl. 2003;86:555-8.

PMID:
14753505
44.

The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison).

Hynynen K, McDannold N, Martin H, Jolesz FA, Vykhodtseva N.

Ultrasound Med Biol. 2003 Mar;29(3):473-81.

PMID:
12706199
45.

Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits.

Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA.

Radiology. 2001 Sep;220(3):640-6.

PMID:
11526261
46.

Apoptosis in ultrasound-produced threshold lesions in the rabbit brain.

Vykhodtseva N, McDannold N, Martin H, Bronson RT, Hynynen K.

Ultrasound Med Biol. 2001 Jan;27(1):111-7.

PMID:
11295277
47.

MRI detection of the thermal effects of focused ultrasound on the brain.

Vykhodtseva N, Sorrentino V, Jolesz FA, Bronson RT, Hynynen K.

Ultrasound Med Biol. 2000 Jun;26(5):871-80.

PMID:
10942834
48.

Thermal effects of focused ultrasound on the brain: determination with MR imaging.

Hynynen K, Vykhodtseva NI, Chung AH, Sorrentino V, Colucci V, Jolesz FA.

Radiology. 1997 Jul;204(1):247-53.

PMID:
9205255
49.

Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo.

Vykhodtseva NI, Hynynen K, Damianou C.

Ultrasound Med Biol. 1995;21(7):969-79.

PMID:
7491751
50.

Supplemental Content

Loading ...
Support Center